FDA nominee director Dr. Margaret Hamburg will tell lawmakers today that the agency is in need of a boost in public confidence and will come down hard on the side of food and drug safety--areas that the agency has fallen short on in recent years. But her prepared remarks also underscore a commitment to innovation. Drug makers will be watching closely to see whether the FDA's emphasis on safety will trump its desire to usher in a new generation of therapeutics. Report